The Limited Times

Now you can see non-English news...

[US stocks] Vaccines stimulate the Dow to rise 2.95%, home economy stocks suffer, and Zoom falls 17.37%

2020-11-09T23:11:37.477Z


Pfizer and BioNTech of Germany announced that the 2019 novel coronavirus (COVID-19) vaccine jointly developed has an effective rate of 90%. In addition, the uncertainty of the US election is gradually fading, investors are looking forward to it


world economy

Written by: Li Fuyuan

2020-11-10 05:59

Last update date: 2020-11-10 06:11

Pfizer and BioNTech of Germany announced that the 2019 novel coronavirus (COVID-19) vaccine jointly developed by the United States has an effective rate of 90%. Coupled with the fading uncertainty of the US general election, investors are looking forward to a full economic restart, stimulating European and American stock markets The price of gold fell sharply, and crude oil futures soared.

The three major U.S. indexes all hit record highs on Monday. The Dow Jones Industrial Average opened 1144 points higher and reached a new high of 29,933.83 points, which is close to the 30,000 point mark. The S&P 500 Index also broke the top after opening a high gap, reaching the highest level. At 3645.99 points, the Nasdaq index was as high as 12108.07 points; however, the end of the market rebounded sharply, only the Dow and the benchmark index still rose, and the Nasdaq fell even more dragged by the penetration of leading technology stocks.

The Dow closed at 29157.97 points, up 834.57 points or 2.95%; the Nasdaq fell 181.45 points or 1.53% to close at 11713.78 points; the standard index rose 41.06 points or 1.17% to close at 3550.5 points.

In response to the progress of vaccine research and development, the home economy and home office concept stocks were sold off. Microsoft closed at US$218.39 per share, down 2.38%, Facebook reported US$278.77, down 4.99%, Apple reported US$116.32, down 2%, Amazon and Netflix respectively. Down 5.06% and 8.59%, Zoom fell 17.37%, closing at $413.24 per share.

Anthony Fauci, chief infectious disease expert of the White House, said that a vaccine with an effective rate of 50% to 60% is acceptable; and according to the requirements of the FDA (US Food and Drug Administration), a vaccine with an effectiveness of more than 50% can be approved for marketing. .

After Pfizer released the vaccine test data, the yield of U.S. Treasury rose sharply, the price of gold fell sharply, and the price of crude oil futures soared.

[US Stocks] Wall Street's stock market was roughly flat this week, setting its best performance in the past six months

U.S. stocks rose by technology stocks

[US Stocks] European and American stocks are all looking better

U.S. stocks

Source: hk1

All news articles on 2020-11-09

You may like

News/Politics 2024-02-21T17:22:19.849Z
News/Politics 2024-02-22T17:13:27.184Z

Trends 24h

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.